Covered recipient · General Payments record
KAJAL PATEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$440.31
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.23 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $74.56 | 4 |
| Lundbeck LLC | $31.91 | 2 |
| Esperion Therapeutics, Inc. | $22.15 | 1 |
| ABBVIE INC. | $21.80 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.96 | 1 |
| Lilly USA, LLC | $14.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.80 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107805773 | CMS |
| Esperion Therapeutics, Inc. | $22.15 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129473794 | CMS |
| Lilly USA, LLC | $14.85 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135724785 | CMS |
| Lundbeck LLC | $17.03 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146073284 | CMS |
| Lundbeck LLC | $14.88 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146073286 | CMS |
| Novo Nordisk Inc | $23.71 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100431891 | CMS |
| Novo Nordisk Inc | $16.60 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100232924 | CMS |
| Novo Nordisk Inc | $16.55 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100367251 | CMS |
| Novo Nordisk Inc | $17.70 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100246141 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.96 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119158815 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.